Effects of Fasciolosis on Haematological Parameters in Cattle
Nangarhar University International Journal of Biosciences · 2022
DOI: 10.70436/nuijb.v2i02.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nangarhar University International Journal of Biosciences, 2022. Verfasst von Nasratullah Hematzai und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Bovine fascioliasis is a systemic infection of cattle caused by, Fasciola spp. The objective of this study was to investigate the effect of fasciolosis on hematological parameters in cattle. Materials and Methods: In the present study, 40 local breeds (Watani) bulls and non-pregnant with ages ≥2 years heifers were randomly selected, of which 30 were infected with Fasciola spp and 10 were not infected (control).
Findings
These results indicated that the infected group had significantly lower total red blood cell (RBC) count and Haemoglobin (Hb) levels than in the control group. In contrast, the infected group had a higher total white blood cell (WBC) count (9.3 x103) compared to the not-infected group (7.7 x103).
Conclusion
The hematological findings of the present study suggest that Fasciola spp decreases the total RBC count and Hb levels, leading to anemia.
Zitieren
APA
Hematzai, N., Rawan, A. F., Wahidyar, M. Y., & Hasanzai, N. (2022). Effects of Fasciolosis on Haematological Parameters in Cattle. Nangarhar University International Journal of Biosciences. https://doi.org/10.70436/nuijb.v2i02.38
Vancouver
Hematzai N, Rawan AF, Wahidyar MY, Hasanzai N. Effects of Fasciolosis on Haematological Parameters in Cattle. Nangarhar University International Journal of Biosciences. 2022. doi:10.70436/nuijb.v2i02.38
BibTeX
@article{Hematzai2022,
author = {Hematzai, Nasratullah and Rawan, Ahamd Farid and Wahidyar, Mohammad Yousof and Hasanzai, Nasirweda},
title = {Effects of Fasciolosis on Haematological Parameters in Cattle},
journal = {Nangarhar University International Journal of Biosciences},
year = {2022},
doi = {10.70436/nuijb.v2i02.38}
}
EUVIMED